Advertisements



The Daily Biotech Pulse: Epizyme"s Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) read more.....»»

Category: blogSource: benzingaFeb 14th, 2020

The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar"s Opioid Drug

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 13.) 0 read more.....»»

Category: blogSource: benzingaJan 14th, 2020

The Daily Biotech Pulse: Endo"s Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 19) 0 read more.....»»

Category: blogSource: benzingaNov 20th, 2019

The Daily Biotech Pulse: Cheery Results For Sage"s Depression Drug, UniQure Offering, Axsome Aces Study Of Headache Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 4) Adaptive Biotechnologies Corp (NASDAQ: ADPT) Bi.....»»

Category: earningsSource: benzingaSep 5th, 2019

The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Bi.....»»

Category: earningsSource: benzingaAug 16th, 2019

The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 15) read more.....»»

Category: blogSource: benzingaAug 16th, 2019

The Daily Biotech Pulse: Regeneron"s Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 13) read more.....»»

Category: blogSource: benzingaAug 14th, 2019

The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 1) read more.....»»

Category: blogSource: benzingaAug 1st, 2019

The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 22) read more.....»»

Category: blogSource: benzingaJul 23rd, 2019

The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi"s BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 9) read more.....»»

Category: blogSource: benzingaJul 10th, 2019

Drug stock soars 250% on pneumonia treatment review

Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Baxdela (delafloxacin) for priority review......»»

Category: topSource: moneycentralJun 19th, 2019

Drug stock soars 250 percent on pneumonia treatment review

Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Baxdela (delafloxacin) for priority review......»»

Category: topSource: moneycentralJun 19th, 2019

Drug stock soars 250 percent on pneumonia treatment review

Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Baxdela (delafloxacin) for priority review......»»

Category: topSource: moneycentralJun 19th, 2019

Drug stock soars after FDA gives nod to pneumonia treatment

Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Baxdela (delafloxacin) for priority review......»»

Category: topSource: moneycentralJun 19th, 2019

The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 10) read more.....»»

Category: blogSource: benzingaJun 11th, 2019

The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-.....»»

Category: earningsSource: benzingaJun 11th, 2019

The Daily Biotech Pulse: Breakthrough Therapy Designation For Iovance, Guardant Prices Offering, 2 Stocks to Debut

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 21) read more.....»»

Category: blogSource: benzingaMay 23rd, 2019

The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on May 21) read more.....»»

Category: blogSource: benzingaMay 22nd, 2019

The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on May 21) Array Biopharma Inc (NASDAQ: ARRY) (announced positive la.....»»

Category: earningsSource: benzingaMay 22nd, 2019

The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on May 16) read more.....»»

Category: blogSource: benzingaMay 17th, 2019

The Daily Biotech Pulse: FDA Accepts Alder"s Migraine Drug Application, Gritstone Offering, Lilly"s Chinese Sale

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 22) read more.....»»

Category: blogSource: benzingaApr 23rd, 2019